Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Winn

Showing results (261-270 of 414) with videos related to

Pageof 42
Sort By:
Journal of Medicinal Chemistry|August 14, 1998
Pyrrolidine-3-carboxylic acids as endothelin antagonists. 3. Discovery of a potent, 2-nonaryl, highly selective ETA antagonist (A-216546)G Liu, K J Henry, B G Szczepankiewicz, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1996
Pharmacological characterization of A-127722: an orally active and highly potent ETA-selective receptor antagonistT J Opgenorth, A L Adler, S V Calzadilla, et al.
Bioorganic & Medicinal Chemistry|July 31, 1999
Discovery of a series of pyrrolidine-based endothelin receptor antagonists with enhanced ET(A) receptor selectivityS A Boyd, R A Mantei, A S Tasker, et al.
Journal of Medicinal Chemistry|March 1, 1996
2,4-Diarylpyrrolidine-3-carboxylic acids--potent ETA selective endothelin receptor antagonists. 1. Discovery of A-127722M Winn, T W von Geldern, T J Opgenorth, et al.
American Journal of Epidemiology|September 16, 2017
THE AUTHORS REPLYAnnah B Wyss, Mia Hashibe, Yuan-Chin Amy Lee, et al.
Journal of the National Cancer Institute. Monographs|May 16, 2020
An Evaluation of the Utility of Big Data to Supplement Cancer Treatment Information: Linkage Between IQVIA Pharmacy Database and the Surveillance, Epidemiology, and End Results ProgramQuyen Tran, Joan L Warren, Michael J Barrett, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 24, 2010
Coffee and tea intake and risk of head and neck cancer: pooled analysis in the international head and neck cancer epidemiology consortiumCarlotta Galeone, Alessandra Tavani, Claudio Pelucchi, et al.
Acta Crystallographica. Section D, Biological Crystallography|September 27, 2006
SPINE workshop on automated X-ray analysis: a progress reportM Bahar, C Ballard, S X Cohen, et al.
American Journal of Epidemiology|October 17, 2016
Smokeless Tobacco Use and the Risk of Head and Neck Cancer: Pooled Analysis of US Studies in the INHANCE ConsortiumAnnah B Wyss, Mia Hashibe, Yuan-Chin Amy Lee, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 11, 2016
Population-Based Precision Cancer Screening: A Symposium on Evidence, Epidemiology, and Next StepsPamela M Marcus, Nora Pashayan, Timothy R Church, et al.
Pageof 42

Showing results (261-270 of 414) with videos related to

Sort By:
Pageof 42
Journal of Medicinal Chemistry|August 14, 1998
Pyrrolidine-3-carboxylic acids as endothelin antagonists. 3. Discovery of a potent, 2-nonaryl, highly selective ETA antagonist (A-216546)G Liu, K J Henry, B G Szczepankiewicz, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1996
Pharmacological characterization of A-127722: an orally active and highly potent ETA-selective receptor antagonistT J Opgenorth, A L Adler, S V Calzadilla, et al.
Bioorganic & Medicinal Chemistry|July 31, 1999
Discovery of a series of pyrrolidine-based endothelin receptor antagonists with enhanced ET(A) receptor selectivityS A Boyd, R A Mantei, A S Tasker, et al.
Journal of Medicinal Chemistry|March 1, 1996
2,4-Diarylpyrrolidine-3-carboxylic acids--potent ETA selective endothelin receptor antagonists. 1. Discovery of A-127722M Winn, T W von Geldern, T J Opgenorth, et al.
American Journal of Epidemiology|September 16, 2017
THE AUTHORS REPLYAnnah B Wyss, Mia Hashibe, Yuan-Chin Amy Lee, et al.
Journal of the National Cancer Institute. Monographs|May 16, 2020
An Evaluation of the Utility of Big Data to Supplement Cancer Treatment Information: Linkage Between IQVIA Pharmacy Database and the Surveillance, Epidemiology, and End Results ProgramQuyen Tran, Joan L Warren, Michael J Barrett, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 24, 2010
Coffee and tea intake and risk of head and neck cancer: pooled analysis in the international head and neck cancer epidemiology consortiumCarlotta Galeone, Alessandra Tavani, Claudio Pelucchi, et al.
Acta Crystallographica. Section D, Biological Crystallography|September 27, 2006
SPINE workshop on automated X-ray analysis: a progress reportM Bahar, C Ballard, S X Cohen, et al.
American Journal of Epidemiology|October 17, 2016
Smokeless Tobacco Use and the Risk of Head and Neck Cancer: Pooled Analysis of US Studies in the INHANCE ConsortiumAnnah B Wyss, Mia Hashibe, Yuan-Chin Amy Lee, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 11, 2016
Population-Based Precision Cancer Screening: A Symposium on Evidence, Epidemiology, and Next StepsPamela M Marcus, Nora Pashayan, Timothy R Church, et al.
Pageof 42